Dell Technologies Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Dell Technologies Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 30, 2026 | $113.54B | Mar 16, 2026 |
| FY2025 | Jan 31, 2025 | $23.93B | Mar 25, 2025 |
| FY2025 | Nov 1, 2024 | $24.37B | Mar 25, 2025 |
| FY2025 | Aug 2, 2024 | $25.03B | Mar 25, 2025 |
| FY2025 | May 3, 2024 | $22.24B | Mar 25, 2025 |
| FY2025 | Feb 2, 2024 | $22.32B | Mar 25, 2025 |
| FY2025 | Nov 3, 2023 | $22.25B | Mar 25, 2025 |
| FY2025 | Aug 4, 2023 | $22.93B | Mar 25, 2025 |
| FY2025 | May 5, 2023 | $20.92B | Mar 25, 2025 |
| FY2025 | Feb 3, 2023 | $102.30B | Mar 25, 2025 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Feb 2, 2018 | $21.94B | Mar 29, 2018 |
| FY2018 | Nov 3, 2017 | $19.61B | Mar 29, 2018 |
| FY2018 | Aug 4, 2017 | $19.30B | Mar 29, 2018 |
| FY2018 | May 5, 2017 | $17.82B | Mar 29, 2018 |
| FY2018 | Feb 3, 2017 | $20.07B | Mar 29, 2018 |
| FY2018 | Oct 28, 2016 | $16.25B | Mar 29, 2018 |
| FY2018 | Jul 29, 2016 | $13.08B | Mar 29, 2018 |
| FY2018 | Apr 29, 2016 | $12.24B | Mar 29, 2018 |
| FY2017 | Jan 29, 2016 | $12.68B | Mar 31, 2017 |
| FY2017 | Oct 30, 2015 | $12.67B | Mar 31, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 30, 2026 | $22.71B | Mar 16, 2026 |
| FY2025 | Jan 31, 2025 | $5.68B | Mar 25, 2025 |
| FY2025 | Nov 1, 2024 | $5.36B | Mar 25, 2025 |
| FY2025 | Aug 2, 2024 | $5.36B | Mar 25, 2025 |
| FY2025 | May 3, 2024 | $4.85B | Mar 25, 2025 |
| FY2025 | Feb 2, 2024 | $5.37B | Mar 25, 2025 |
| FY2025 | Nov 3, 2023 | $5.20B | Mar 25, 2025 |
| FY2025 | Aug 4, 2023 | $5.42B | Mar 25, 2025 |
| FY2025 | May 5, 2023 | $5.08B | Mar 25, 2025 |
| FY2025 | Feb 3, 2023 | $22.69B | Mar 25, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 30, 2026 | $5.94B | Mar 16, 2026 |
| FY2025 | Jan 31, 2025 | $1.53B | Mar 25, 2025 |
| FY2025 | Nov 1, 2024 | $1.18B | Mar 25, 2025 |
| FY2025 | Aug 2, 2024 | $887.00M | Mar 25, 2025 |
| FY2025 | May 3, 2024 | $997.00M | Mar 25, 2025 |
| FY2025 | Feb 2, 2024 | $1.21B | Mar 25, 2025 |
| FY2025 | Nov 3, 2023 | $1.05B | Mar 25, 2025 |
| FY2025 | Aug 4, 2023 | $489.00M | Mar 25, 2025 |
| FY2025 | May 5, 2023 | $637.00M | Mar 25, 2025 |
| FY2025 | Feb 3, 2023 | $2.44B | Mar 25, 2025 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 30, 2026 | $8.15B | Mar 16, 2026 |
| FY2025 | Jan 31, 2025 | $2.16B | Mar 25, 2025 |
| FY2025 | Nov 1, 2024 | $1.72B | Mar 25, 2025 |
| FY2025 | Aug 2, 2024 | $1.39B | Mar 25, 2025 |
| FY2025 | May 3, 2024 | $965.00M | Mar 25, 2025 |
| FY2025 | Feb 2, 2024 | $1.55B | Mar 25, 2025 |
| FY2025 | Nov 3, 2023 | $1.54B | Mar 25, 2025 |
| FY2025 | Aug 4, 2023 | $1.19B | Mar 25, 2025 |
| FY2025 | May 5, 2023 | $1.13B | Mar 25, 2025 |
| FY2025 | Feb 3, 2023 | $5.77B | Mar 25, 2025 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 30, 2026 | $3.14B | Mar 16, 2026 |
| FY2026 | Jan 31, 2025 | $3.06B | Mar 16, 2026 |
| FY2026 | Feb 2, 2024 | $2.80B | Mar 16, 2026 |
| FY2024 | Aug 4, 2023 | $705.00M | Sep 12, 2023 |
| FY2024 | May 5, 2023 | $688.00M | Jun 12, 2023 |
| FY2025 | Feb 3, 2023 | $2.78B | Mar 25, 2025 |
| FY2024 | Jul 29, 2022 | $626.00M | Sep 12, 2023 |
| FY2024 | Apr 29, 2022 | $681.00M | Jun 12, 2023 |
| FY2024 | Jan 28, 2022 | $2.58B | Mar 25, 2024 |
| FY2023 | Jan 29, 2021 | $2.46B | Mar 30, 2023 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 30, 2026 | $11.42B | Mar 16, 2026 |
| FY2026 | Jan 31, 2025 | $11.95B | Mar 16, 2026 |
| FY2026 | Feb 2, 2024 | $12.86B | Mar 16, 2026 |
| FY2024 | Aug 4, 2023 | $3.52B | Sep 12, 2023 |
| FY2024 | May 5, 2023 | $3.26B | Jun 12, 2023 |
| FY2025 | Feb 3, 2023 | $14.14B | Mar 25, 2025 |
| FY2024 | Jul 29, 2022 | $3.54B | Sep 12, 2023 |
| FY2024 | Apr 29, 2022 | $3.55B | Jun 12, 2023 |
| FY2024 | Jan 28, 2022 | $14.66B | Mar 25, 2024 |
| FY2023 | Jan 29, 2021 | $14.00B | Mar 30, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 30, 2026 | $11.19B | Mar 16, 2026 |
| FY2026 | Jan 31, 2025 | $4.52B | Mar 16, 2026 |
| FY2026 | Feb 2, 2024 | $8.68B | Mar 16, 2026 |
| FY2024 | Aug 4, 2023 | $4.99B | Sep 12, 2023 |
| FY2024 | May 5, 2023 | $1.78B | Jun 12, 2023 |
| FY2025 | Feb 3, 2023 | $3.57B | Mar 25, 2025 |
| FY2024 | Jul 29, 2022 | $455.00M | Sep 12, 2023 |
| FY2024 | Apr 29, 2022 | ($269.00M) | Jun 12, 2023 |
| FY2024 | Jan 28, 2022 | $10.31B | Mar 25, 2024 |
| FY2023 | Jan 29, 2021 | $11.41B | Mar 30, 2023 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 30, 2026 | $2.63B | Mar 16, 2026 |
| FY2026 | Jan 31, 2025 | $2.65B | Mar 16, 2026 |
| FY2026 | Feb 2, 2024 | $2.76B | Mar 16, 2026 |
| FY2024 | Aug 4, 2023 | $1.33B | Sep 12, 2023 |
| FY2024 | May 5, 2023 | $701.00M | Jun 12, 2023 |
| FY2025 | Feb 3, 2023 | $3.00B | Mar 25, 2025 |
| FY2024 | Jul 29, 2022 | $1.50B | Sep 12, 2023 |
| FY2024 | Apr 29, 2022 | $690.00M | Jun 12, 2023 |
| FY2024 | Jan 28, 2022 | $2.80B | Mar 25, 2024 |
| FY2023 | Jan 29, 2021 | $2.08B | Mar 30, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 30, 2026 | $101.29B | Mar 16, 2026 |
| FY2026 | Jan 31, 2025 | $79.75B | Mar 16, 2026 |
| FY2025 | Feb 2, 2024 | $82.13B | Mar 25, 2025 |
| FY2024 | Aug 4, 2023 | $85.66B | Sep 12, 2023 |
| FY2024 | May 5, 2023 | $84.09B | Jun 12, 2023 |
| FY2024 | Feb 3, 2023 | $89.61B | Mar 25, 2024 |
| FY2023 | Jan 28, 2022 | $92.74B | Mar 30, 2023 |
| FY2022 | Jan 29, 2021 | $123.42B | Mar 24, 2022 |
| FY2021 | Jan 31, 2020 | $118.86B | Mar 26, 2021 |
| FY2020 | Feb 1, 2019 | $111.82B | Mar 27, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 30, 2026 | $103.76B | Mar 16, 2026 |
| FY2026 | Jan 31, 2025 | $81.13B | Mar 16, 2026 |
| FY2025 | Feb 2, 2024 | $84.26B | Mar 25, 2025 |
| FY2024 | Aug 4, 2023 | $88.34B | Sep 12, 2023 |
| FY2024 | May 5, 2023 | $87.02B | Jun 12, 2023 |
| FY2024 | Feb 3, 2023 | $92.64B | Mar 25, 2024 |
| FY2023 | Jan 28, 2022 | $94.32B | Mar 30, 2023 |
| FY2022 | Jan 29, 2021 | $115.39B | Mar 24, 2022 |
| FY2021 | Jan 31, 2020 | $115.08B | Mar 26, 2021 |
| FY2020 | Feb 1, 2019 | $111.57B | Mar 27, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 30, 2026 | ($2.47B) | Mar 16, 2026 |
| FY2026 | Jan 31, 2025 | ($1.48B) | Mar 16, 2026 |
| FY2025 | Feb 2, 2024 | ($2.23B) | Mar 25, 2025 |
| FY2024 | Aug 4, 2023 | ($2.77B) | Sep 12, 2023 |
| FY2024 | May 5, 2023 | ($3.02B) | Jun 12, 2023 |
| FY2024 | Feb 3, 2023 | ($3.12B) | Mar 25, 2024 |
| FY2023 | Jan 28, 2022 | ($1.69B) | Mar 30, 2023 |
| FY2022 | Jan 29, 2021 | $2.48B | Mar 24, 2022 |
| FY2021 | Jan 31, 2020 | ($1.57B) | Mar 26, 2021 |
| FY2020 | Feb 1, 2019 | ($5.77B) | Mar 27, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 30, 2026 | $19.55B | Mar 16, 2026 |
| FY2026 | Jan 31, 2025 | $19.12B | Mar 16, 2026 |
| FY2026 | Feb 2, 2024 | $19.70B | Mar 16, 2026 |
| FY2024 | Aug 4, 2023 | $19.64B | Sep 12, 2023 |
| FY2024 | May 5, 2023 | $19.66B | Jun 12, 2023 |
| FY2025 | Feb 3, 2023 | $19.68B | Mar 25, 2025 |
| FY2023 | Jan 28, 2022 | $19.77B | Mar 30, 2023 |
| FY2023 | Jan 29, 2021 | $20.03B | Mar 30, 2023 |
| FY2022 | Jan 31, 2020 | $21.16B | Mar 24, 2022 |
| FY2021 | Feb 1, 2019 | $40.09B | Mar 26, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 30, 2026 | $3.33B | Mar 16, 2026 |
| FY2026 | Jan 31, 2025 | ($1.16B) | Mar 16, 2026 |
| FY2025 | Feb 2, 2024 | ($4.45B) | Mar 25, 2025 |
| FY2024 | Aug 4, 2023 | ($6.25B) | Sep 12, 2023 |
| FY2024 | May 5, 2023 | ($6.43B) | Jun 12, 2023 |
| FY2024 | Feb 3, 2023 | ($6.73B) | Mar 25, 2024 |
| FY2023 | Jan 28, 2022 | ($8.19B) | Mar 30, 2023 |
| FY2022 | Jan 29, 2021 | ($13.75B) | Mar 24, 2022 |
| FY2021 | Jan 31, 2020 | ($16.89B) | Mar 26, 2021 |
| FY2020 | Feb 1, 2019 | ($21.35B) | Mar 27, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 30, 2026 | $11.53B | Mar 16, 2026 |
| FY2026 | Jan 31, 2025 | $3.63B | Mar 16, 2026 |
| FY2025 | Feb 2, 2024 | $7.37B | Mar 25, 2025 |
| FY2024 | Aug 4, 2023 | $8.36B | Sep 12, 2023 |
| FY2024 | May 5, 2023 | $7.63B | Jun 12, 2023 |
| FY2024 | Feb 3, 2023 | $8.61B | Mar 25, 2024 |
| FY2023 | Jan 28, 2022 | $9.48B | Mar 30, 2023 |
| FY2022 | Jan 29, 2021 | $9.51B | Mar 24, 2022 |
| FY2021 | Jan 31, 2020 | $9.30B | Mar 26, 2021 |
| FY2020 | Feb 1, 2019 | $9.68B | Mar 27, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 30, 2026 | $31.50B | Mar 16, 2026 |
| FY2026 | Jan 31, 2025 | $24.57B | Mar 16, 2026 |
| FY2025 | Feb 2, 2024 | $25.99B | Mar 25, 2025 |
| FY2024 | Aug 4, 2023 | $27.14B | Sep 12, 2023 |
| FY2024 | May 5, 2023 | $28.43B | Jun 12, 2023 |
| FY2024 | Feb 3, 2023 | $29.59B | Mar 25, 2024 |
| FY2023 | Jan 28, 2022 | $26.95B | Mar 30, 2023 |
| FY2022 | Jan 29, 2021 | $39.22B | Mar 24, 2022 |
| FY2021 | Jan 31, 2020 | $52.06B | Mar 26, 2021 |
| FY2020 | Feb 1, 2019 | $53.52B | Mar 27, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 30, 2026 | 8 | Mar 16, 2026 |
| FY2025 | Jan 31, 2025 | 2 | Mar 25, 2025 |
| FY2025 | Nov 1, 2024 | 1 | Mar 25, 2025 |
| FY2025 | Aug 2, 2024 | 1 | Mar 25, 2025 |
| FY2025 | May 3, 2024 | 1 | Mar 25, 2025 |
| FY2025 | Feb 2, 2024 | 1 | Mar 25, 2025 |
| FY2025 | Nov 3, 2023 | 1 | Mar 25, 2025 |
| FY2025 | Aug 4, 2023 | 0 | Mar 25, 2025 |
| FY2025 | May 5, 2023 | 0 | Mar 25, 2025 |
| FY2025 | Feb 3, 2023 | 3 | Mar 25, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 30, 2026 | 8 | Mar 16, 2026 |
| FY2025 | Jan 31, 2025 | 2 | Mar 25, 2025 |
| FY2025 | Nov 1, 2024 | 1 | Mar 25, 2025 |
| FY2025 | Aug 2, 2024 | 1 | Mar 25, 2025 |
| FY2025 | May 3, 2024 | 1 | Mar 25, 2025 |
| FY2025 | Feb 2, 2024 | 1 | Mar 25, 2025 |
| FY2025 | Nov 3, 2023 | 1 | Mar 25, 2025 |
| FY2025 | Aug 4, 2023 | 0 | Mar 25, 2025 |
| FY2025 | May 5, 2023 | 0 | Mar 25, 2025 |
| FY2025 | Feb 3, 2023 | 3 | Mar 25, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 30, 2026 | 652.00M | Mar 16, 2026 |
| FY2026 | Jan 31, 2025 | 696.00M | Mar 16, 2026 |
| FY2025 | Feb 2, 2024 | 705.00M | Mar 25, 2025 |
| FY2024 | Aug 4, 2023 | 724.00M | Sep 12, 2023 |
| FY2024 | May 5, 2023 | 729.00M | Jun 12, 2023 |
| FY2024 | Feb 3, 2023 | 716.00M | Mar 25, 2024 |
| FY2023 | Jan 28, 2022 | 757.00M | Mar 30, 2023 |
| FY2022 | Jan 29, 2021 | 753.00M | Mar 24, 2022 |
| FY2021 | Jan 31, 2020 | 743.00M | Mar 26, 2021 |
| FY2020 | Feb 1, 2019 | 719.00M | Mar 27, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 30, 2026 | $1.46B | Mar 16, 2026 |
| FY2026 | Jan 31, 2025 | $1.28B | Mar 16, 2026 |
| FY2026 | Feb 2, 2024 | $1.07B | Mar 16, 2026 |
| FY2024 | Aug 4, 2023 | $545.00M | Sep 12, 2023 |
| FY2024 | May 5, 2023 | $276.00M | Jun 12, 2023 |
| FY2025 | Feb 3, 2023 | $964.00M | Mar 25, 2025 |
| FY2024 | Jul 29, 2022 | $490.00M | Sep 12, 2023 |
| FY2024 | Apr 29, 2022 | $248.00M | Jun 12, 2023 |
| FY2024 | Jan 28, 2022 | $0 | Mar 25, 2024 |
| FY2023 | Jan 29, 2021 | $0 | Mar 30, 2023 |